TL;DR
Dr. Dajun Yang, Chairman and CEO of Ascentage Pharma, has been named to The Medicine Maker Power List 2026. This recognition underscores his leadership and impact in the pharmaceutical industry. The announcement was made by GlobeNewswire and is confirmed as of now.
Dr. Dajun Yang, Chairman and CEO of Ascentage Pharma, has been named to The Medicine Maker Power List 2026, an annual ranking recognizing influential leaders in the pharmaceutical industry. This recognition highlights his leadership and contributions to drug development and innovation, and it is confirmed by GlobeNewswire as of March 2026.
Get business pricing on office and shipping supplies
- Business-only prices and quantity discounts
- Tax-exempt purchasing
- Multiple users, one account, clear invoices
While the list is publicly published and the selection process is based on industry impact, specific criteria or the selection process details have not been disclosed. The recognition is seen as a significant honor within the pharmaceutical community, emphasizing Yang’s role in advancing drug discovery and company growth.
Impact of the Recognition on Industry and Company
This honor underscores Dr. Yang’s influence in the pharmaceutical sector, highlighting his leadership in driving innovative therapies. It boosts Ascentage Pharma’s reputation in the biotech industry, potentially attracting partnerships, investments, and talent. The recognition also reflects the growing importance of Chinese biotech leaders on the global stage, signaling increased industry influence for Yang and his company.
Products Worth Considering

FLEXISPOT Electric Height-Adjustable Workbench, 48 x 30 Inches, Black

FLEXISPOT EN1 Electric Standing Desk, 48 x 24 in, Black

Dell UltraSharp U4025QW 40-Inch Curved 5K2K WUHD LED Monitor
As an affiliate, we earn on qualifying purchases.
Background on The Medicine Maker Power List and Dr. Yang’s Leadership
The Medicine Maker Power List is an annual ranking that spotlights influential figures in pharmaceutical research, development, and leadership. Past lists have included industry giants and emerging leaders, emphasizing innovation and impact. Dr. Dajun Yang has been leading Ascentage Pharma since its founding, overseeing the development of novel therapies in oncology and hematology. Under his guidance, the company has progressed multiple candidates into clinical trials and expanded its global presence.
Prior to this recognition, Yang has been acknowledged for his contributions to drug innovation and leadership within China’s biotech sector, which has gained increasing international attention in recent years.
“Dr. Dajun Yang’s inclusion on The Medicine Maker Power List 2026 reflects his significant influence and leadership in pharmaceutical innovation.”
— GlobeNewswire
Details of the Selection Process and Future Recognition
It is not yet clear how the selection process was conducted or the specific criteria used by The Medicine Maker. Additionally, it remains unknown whether this recognition will lead to further awards or industry influence for Dr. Yang or Ascentage Pharma.
Next Steps for Dr. Yang and Ascentage Pharma
Following this recognition, Dr. Yang and his team are expected to continue advancing their pipeline of innovative therapies. The company may also leverage this recognition to strengthen industry partnerships and attract investment. Further announcements regarding clinical progress or strategic initiatives are anticipated in the coming months.
Key Questions
What is The Medicine Maker Power List?
The Medicine Maker Power List is an annual ranking that highlights influential leaders and innovators in the pharmaceutical and biotech industries, based on their impact and contributions to drug development and industry progress.
Why was Dr. Dajun Yang recognized?
He was recognized for his leadership in advancing innovative medicines and his influence within the pharmaceutical industry, particularly through his role at Ascentage Pharma.
What does this recognition mean for Ascentage Pharma?
This honor enhances the company’s reputation, potentially attracting new partnerships, investments, and talent, while also elevating Dr. Yang’s profile as a global biotech leader.
Are there other notable achievements by Dr. Yang?
Yes, Dr. Yang has been acknowledged for his contributions to drug discovery, leadership in biotech innovation, and for positioning Ascentage Pharma as a growing player in oncology and hematology.
Will Dr. Yang receive further industry awards?
It is not yet known if this recognition will lead to additional awards, but it positions him as a prominent figure likely to be considered for future honors.
Source: primary
